Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ADVANCE_HTA

Financiado

Cerrado

Advancing and strengthening the methodological tools and practices relating to t...

Advancing and strengthening the methodological tools and practices relating to the application and implementation of Health Technology Assessment HTA The use of HTA has increased recently in Europe and more widely (e.g. Americas) to enable evidence-based coverage decisions and improve efficiency in resource allocation. HTA has often resulted in different coverage decisions acro... ver más

31/12/2015

LONDON SCHOOL OF E...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 14 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-12-31 No tenemos la información de la convocatoria

0% 74% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

14 Participantes

LONDON SCHOOL OF ECONOMICS A...

0.00€ | Lider

UCLM

N.D. | Participante

INSTITUTE FOR ECONOMIC RESEA...

N.D. | Participante

LSHTM

N.D. | Participante

Proyectos interesantes

IMPACT HTA

Medical Technol...

Data Science

5M€ Cerrado

RTI2018-096365-J-I00

Medical Technol...

Data Science

140K€ Cerrado

COMED

Medical Technol...

Data Science

3M€ Cerrado

PID2019-104907GB-I00

Medical Technol...

Data Science

21K€ Cerrado

ECO2016-75439-P

Medical Technol...

Data Science

25K€ Cerrado

Dynamic CER

Medical Technol...

Data Science

185K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The use of HTA has increased recently in Europe and more widely (e.g. Americas) to enable evidence-based coverage decisions and improve efficiency in resource allocation. HTA has often resulted in different coverage decisions across settings despite the same evidence being used for this purpose. This may reflect in part societal preferences about value, priorities or risk perceptions, suggesting a significant need for methodological improvements and extensions. The fundamental objective of ADVANCE_HTA is to contribute to advancements in the methods for HTA in European and other settings by involving the wider stakeholder community in areas actively and heavily debated given their implications for decision-making and resource allocation, as follows: • First, the issue around value for money and the different approaches surrounding current thresholds for resource allocation; • Second, the concept of value assessment, and the factors that need to be considered beyond cost effectiveness, such as disease severity; • Third, to improve the quality of the evidence required for and the methods associated with the assessment of rare diseases; • Fourth, to advance the debate in the elicitation of preferences by deriving these in more realistic settings within the patient community in the wider EU; • Fifth, to advance the debate on the suitability of current HTA tools across different categories of medical devices (e.g. diagnostics); and • Sixth, to improve the implementation and capacity building of HTA including outside Europe, where HTA is considered explicitly in decision-making. ADVANCE_HTA aims to broaden the spectrum, complement and address areas of intense methodological debate in the application, use and implementation of HTA. It also aims to improve HTA methods, which can be taken further by competent authorities nationally whilst supplementing the work of supra-national bodies (e.g. EUnetHTA) towards a common understanding of choices in health care decision-making.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores